Please provide your email address to receive an email when new articles are posted on . Pegcetacoplan reduced proteinuria in patients with rare complement-mediated glomerular diseases vs. placebo.

Dulaglutide vs placebo was associated with significant reductions in glomerular filtration rates among youth with type 2 diabetes. Dulaglutide decreases estimated glomerular filtration rate (eGFR) and ...

Associate Professor in Microvascular Medicine, Rebecca Foster, explores therapeutic approaches to improve kidney health for ...

A wave of new therapies is transforming care for glomerular diseases, and nowhere is the momentum faster than in immunoglobulin A (IgA) nephropathy. At the National Kidney Foundation (NKF) Spring ...

Treatment with atacicept led to a statistically significant 42% reduction in UPCR compared with placebo at week 36. Atacicept, an investigational BAFF (B-cell activating factor)/APRIL (a proliferation ...

HOUSTON -- A novel self-administered shot that inhibits two key immunoregulatory cytokines reduced proteinuria in patients with IgA nephropathy, interim findings from the phase III ORIGIN 3 trial ...

Foamy pee may be a sign of proteinuria, a condition in which protein concentrations in the urine are high, typically due to a kidney-related issue. There may also be harmless explanations for bubbly ...

"Medical Journeys" is a set of clinical resources reviewed by doctors, meant for physicians and other healthcare professionals as well as the patients they serve. Each episode of this journey through ...